<DOC>
	<DOC>NCT00284856</DOC>
	<brief_summary>This is a multicenter study to evaluate the efficacy and safety of MK0476 versus placebo in participants with chronic asthma who actively smoke cigarettes.</brief_summary>
	<brief_title>Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Participants with chronic asthma who actively smoke at least 0.5 to no more than 2 packs of cigarettes a day Participant cannot have a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) or emphysema.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>